Whereas PEAK1 K140Q was present within a subclone representing 24% of tumor cells (CCF = 0.24, s = 1), LRP5 A65V was estimated to be present in only 2% of cells in the primary tumor (CCF = 0.02, s = 1). Here, LRP5 is linked to neoplasm.